MRI and ultrasound reveal early signs of rheumatoid arthritis
Rheumatoid arthritis, which affects approximately 2.9 million people in Europe, can be difficult to differentiate from other forms of arthritis. Without an early diagnosis, however, it is impossible to assess the true effect of promising early intervention strategies. Could an alternative diagnostic imaging strategy be the answer?
Industry News: Supersonic Imagine reinvigorates ultrasound R&D
March 10th 2009It wasn’t too long ago that ultrasound was a roiling sea of innovation and new product releases, spurred by a rivalry among Diasonics, ATL, Hewlett-Packard (Agilent Technologies), and Acuson. Since these companies’ acquisition by GE, Philips, and Siemens, the waters have calmed. Supersonic Imagine plans to begin making some waves -- and soon.
Interventional MR imaging represents worthwhile investment
If radiologists could design the perfect modality for guiding interventional procedures, the resulting technology would undoubtedly produce high-quality images without exposing patients to any ionizing radiation. So given the widespread availability of MRI, why are so many interventions still performed in the angiography suite?
Correct modality choice proves essential in head and neck trauma
CT and MRI have a vital part to play in cases of head and neck trauma, but it is important to know which modality to use under the clinical circumstances, according to speakers at Friday’s opening session of the minicourse on major trauma.
Contrast ultrasound could reduce unneeded prostate biopsies
March 9th 2009A protocol involving contrast-enhanced ultrasound could better target tumors and reduce the number of unnecessary prostate biopsies, according to a pair of studies presented Sunday. One of the studies involved more than 2000 patients.
Industry News: GE tunes into European concerns
March 9th 2009Focusing on company technologies aimed at early stage diagnosis, GE Healthcare is advocating disease prevention and presymptomatic detection at the ECR this week. In the context of this “Early Health” model of care, GE addressed an issue Europeans were the first to be concerned about: patient radiation dose.
Emergence of elastography gives renewed impetus and vigor to ultrasound market
Elastography is one of the emerging technologies on display at ECR 2009, reflecting the growing importance of imaging techniques that compare the inherent stiffness of healthy and abnormal tissues in advancing the diagnostic value of ultrasound. Elastography’s clinical applications were discussed at two separate satellite symposia on Saturday and Sunday.
MR vendors look for patient-focused route to success
In the gleaming technical exhibition at ECR 2009, vendors of MRI systems are showing just how their latest innovations will help turn the imaging examination into a faster, less claustrophobic, and altogether more pleasant experience for the patient.
Comment: Vienna, ‘City of My Dreams’
March 9th 2009Vienna has always been a magical place for me. When my wife and I first had an opportunity to visit Europe in 1983, we made sure it was on our itinerary. The fact that our daughter and son were only nine and six years old, respectively, meant that we had to make each city we visited a special place for them. Vienna meant two things for them: dancing white horses and waltz music. Of course, it soon meant other things, such as Sacher-Torte and wiener schnitzel. Even nine- and six-year-olds appreciate good food, and Vienna certainly had a feast of that!
Multislice CT provides boost for COPD patients, but dose concerns persist
Multislice CT continues to spawn new applications in lung imaging, such as software techniques that allow depiction of airway morphology abnormalities in the prevalent chronic obstructive pulmonary disease. But radiologists are still not doing enough to cut the radiation dose while using the latest imaging tools, resulting in unnecessary and potentially hazardous excess exposure, according to some experts.
Changing paradigms for tumor response spark debate
Yes, size does matter, but it is certainly not the only way to monitor the efficacy of cancer treatment. The way in which lesions are measured is extremely important as well, ECR delegates were told at a special focus session on the assessment of tumor response.